Q2 2015 13F Holders as of 6/30/2015
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
90.9M
-
Number of holders
-
233
-
Total shares
-
92.8M
-
Shares change
-
-411K
-
Total reported value, excl. options
-
$3.15B
-
Value change
-
-$17.8M
-
Put/Call ratio
-
1.7
-
Number of buys
-
91
-
Number of sells
-
-131
-
Price
-
$33.99
Significant Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) as of Q2 2015
247 filings reported holding MYGN - MYRIAD GENETICS INC - Common Stock, par value $0.01 per share as of Q2 2015.
MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) has 233 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 92.8M shares
.
Largest 10 shareholders include BAILLIE GIFFORD & CO (10.4M shares), Capital Research Global Investors (8.94M shares), Capital World Investors (8.94M shares), SCOPIA CAPITAL MANAGEMENT LP (6.49M shares), IRIDIAN ASSET MANAGEMENT LLC/CT (5.8M shares), VANGUARD GROUP INC (4.69M shares), FIRST TRUST ADVISORS LP (4.32M shares), ROYCE & ASSOCIATES LLC (2.82M shares), BlackRock Fund Advisors (2.73M shares), and STATE STREET CORP (2.12M shares).
This table shows the top 233 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.